Form 4 Filing for Boston Scientific Corp.

David C. Habiger, a director at Boston Scientific Corp. (BSX), reported the acquisition of company stock on May 19 and May 20, 2026. On May 19, Habiger acquired 2,200 shares of Common Stock at a weighted average price of $56.9451, increasing his post-transaction holdings to 11,628 shares. The following day, May 20, he acquired an additional 2,250 shares at a weighted average price of $55.9195, bringing his total post-transaction shares to 13,878. These transactions were directly owned. Footnote F1 indicates that the 2,200 shares were purchased at prices ranging from $56.93 to $56.96, and footnote F2 states that the 2,250 shares were purchased at prices ranging from $55.85 to $56.00. Habiger has undertaken to provide full information on specific prices upon request.